Use of, and likelihood of using, HIV pre-exposure prophylaxis among men who have sex with men in Europe and Central Asia: Findings from a 2017 large geosocial networking application survey
Bourne, A., Alba, B., Garner, A., Spiteri, G., Pharris, A., Noori, T.
Seasonal influenza vaccination and antiviral use in EU/EEA Member States
Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons.
Quantifying unmet prevention needs among msm in europe through a multi-site bio-behavioural survey
Mirandola, M., Gios, L., Sherriff, N., Marcus, U., Toskin, I., Rosinska, M., Schink, S., Kühlmann-Berenzon, S., Suligoi, B., Folch, C., Nöstlinger, C., Dias, S., Stanekova, D., Klavs, I., Caplinskas, S., Rafila, A., Marin, C., Alexiev, I., Zohrabyan, L., Noori, T., Menel-Lemos, C.
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 5 (15 %) of those living with HIV are not aware of their status. And it takes around three years from HIV infection to diagnosis.
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
Brown, A.E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A.J., Pharris, A., Delpech, V.C., The Ecdc Dublin Declaration Monitoring Network
Infographic: Healthcare-associated infections – a threat to patient safety in Europe
A total of 8.9 million healthcare-associated infections were estimated to occur each year in European hospitals and long-term care facilities.
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Plachouras, D., Kärki, T., Hansen, S., Hopkins, S., Lyytikäinen, O., Moro, M.L., Reilly, J., Zarb, P., Zingg, W., Kinross, P., Weist, K., Monnet, D.L., Suetens, C., The Point Prevalence Survey Study Group
Infographic: Antibiotic resistance – an increasing threat to human health
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden of infections with bacteria resistant to antibiotics on the European population is comparable to that of inﬂuenza, tuberculosis and HIV/AIDS combined.
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations
Migliori, G.B., Sotgiu, G., Rosales-Klintz, S., van der Werf, M.J.